Skip to content

Effect of Ducrosia Anethifolia on post myocardial infarction anxiety

Effect of Ducrosia Anethifolia on anxiety of patients with acute myocardial infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201302034519N5
Enrollment
70
Registered
2013-02-23
Start date
2012-12-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction. Acute myocardial infarction

Interventions

Intervention 1: Group 2(control): Routine treatment + placebo (Perl) two times in a day (6 am and 6 pm). Intervention 2: Group1(intervention): Routine treatment + 100 mg of soft capsule (Perl) contain
Treatment - Other
Group 2(control): Routine treatment + placebo (Perl) two times in a day (6 am and 6 pm).
Group1(intervention): Routine treatment + 100 mg of soft capsule (Perl) containing of the essence of Ducrosia Anethifolia two times in a day (6 am and 6 pm).

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Diagnosed MI based on cardiologist opinion; ability and permitted to take oral tablet; having no history of psychoneurosis disorders; no treatment with antipsychotic drugs; Exclusion criteria: having no ability to communicate with other; suffering from psychoneurosis disorders; treatment with antipsychotic drugs; inducing side effects or drugs interactions;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Patient anxiety. Timepoint: Before intervention. Method of measurement: Spiel Berger questionnare.

Secondary

MeasureTime frame
Patient anxiety. Timepoint: Before and after 48 hours. Method of measurement: Spiel Berger questionnare.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Davood Hekmatpou

Arak University of Medical Sciences

dr_hekmat@arakmu.ac.ir+98 86 1417 3645

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026